Abvc Biopharma (ABVC) Dividends payables (2011 - 2012)
Abvc Biopharma's (ABVC) quarterly Dividends payables came in at $1116.0 in Q2 2012, down 96.46% on a QoQ basis from $31566.0 in Q3 2011.
Abvc Biopharma (ABVC) Dividends payables (2011 - 2012) Analysis & Trends
Abvc Biopharma (ABVC) has 2 years of Dividends payables data on file, last reported at $1116.0 in Q2 2012.
- Quarterly Dividends payables changed N/A year-over-year to $1116.0 in Q2 2012, while the trailing twelve-month figure through Jun 2012 was $1116.0 (changed N/A YoY) and the FY2011 annual result came in at $31566.0, changed N/A from the prior year.
- Dividends payables declined to $1116.0 in Q2 2012, from $31566.0 in the prior quarter.
- In the past five years, Dividends payables ranged from a high of $31566.0 in Q3 2011 to a low of $1116.0 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | - |
| 10 | Abvc Biopharma | 24.23 Mn | 24.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 1,116.00 |
| Sep 30, 2011 | 31,566.00 |